Characteristic | aBeigel | bWang | cGrein | dGoldman | eSpinner |
---|---|---|---|---|---|
Discontinued rate (Remdesivir) 10-day | 9.8% | 11.6% | 7.5% | 10.2% | 4.1% |
Discontinued rate (Remdesivir) 5-day | Â | Â | Â | 4.5% | 2.1% |
Discontinued rate (Control) 10-day | 13.5% | 5.1% | Â | Â | Â |
Discontinued rate (Remdesivir/control) | 0.73 | 2.27 | Â | 2.27f | Â |
Serious adverse events (Remdesivir-10 day) | 24.6% | 18.1% | 22.6% | 34.5% | 5.2% |
Serious adverse events (Remdesivir-5 day) |  |  |  | 21.0% | 4.7% |
Serious adverse events (Control) | 31.6% | 25.6% | Â | Â | 9.0% |
Adverse events (Remdesivir/control) | 0.78 | 0.69 | Â | 1.64 | Â |
Death (Remdesivir-10 day) | 10.9% | 14.2% | 13.2% | 10.7% | 1.6% |
Death (Remdesivir-5 day) |  |  |  | 8.0% | 1.0% |
Death (Control) | 14.8% | 12.8% | Â | Â | 2.0% |